Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group

Gynecologic Oncology(2024)

引用 0|浏览8
暂无评分
摘要
•Niraparib as maintenance treatment demonstrated to be effective in platinum sensitive recurrent OC.•The efficacy data of niraparib are consistent with what was reported in the pivotal study.•Niraparib has been shown to be safe and well tolerated in the overall OC population.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要